Evidence map›Paper›PMID 25098613›Full record

Trial reportPloS one2014

Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica serovars Typhi and Paratyphi A blood isolates from Kolkata, India during 2009-2013.

Shanta Dutta, Surojit Das, Utpala Mitra, Priyanka Jain, Indranil Roy, Shelley S Ganguly, Ujjwayini Ray, Phalguni Dutta, Dilip Kumar Paul

Abstract readClinical Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. A systematic review of antimicrobial resistance of typhoidalThe Indian journal of medical research · 2019
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Sensitivity Pattern OfInfection and drug resistance · 2019
    Article
  13. Genomic and Proteomic Characterizations ofFrontiers in microbiology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Longitudinal Typhoid Fever Trends in India from 2000 to 2015.The American journal of tropical medicine and hygiene · 2018
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shanta DuttaNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Surojit DasNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Utpala MitraNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Priyanka JainNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Indranil RoyCalcutta Medical Research Institute, Kolkata, India.
Shelley S GangulyAdvance Medical Research Institute, Salt Lake, Kolkata, India.
Ujjwayini RayApollo Gleneagles Hospitals, Kolkata, India.
Phalguni DuttaNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Dilip Kumar PaulDr. B. C. Roy Post Graduate Institute of Pediatric Sciences, Kolkata, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enteric fever, caused by Salmonella enterica, remains an unresolved public health problem in India and antimicrobial therapy is the main mode of treatment. The objective of this study was to characterize the Salmonella enterica isolates from Kolkata with respect to their antimicrobial resistance (AMR), virulence profiles and molecular subtypes. Salmonella enterica blood isolates were collected from clinically suspected enteric fever patients attending various hospitals in Kolkata, India from January 2009 to June 2013 and were tested for AMR profiles by standard protocols; for resistance gene transfer by conjugation; for resistance and virulence genes profiles by PCR; and for molecular subtypes by Pulsed Field Gel Electrophoresis (PFGE). A total of 77 Salmonella enterica serovar Typhi (S. Typhi) and 25 Salmonella enterica serovar Paratyphi A (S. Paratyphi A) from Kolkata were included in this study. Although multidrug resistance (resistance to chloramphenicol, ampicillin, co-trimoxazole) was decreasing in S. Typhi (18.2%) and absent in S. Paratyphi A, increased resistance to fluoroquinolone, the current drug of choice, caused growing concern for typhoid treatment. A single, non-conjugative non-IncHI1 plasmid of 180 kb was found in 71.4% multidrug resistant (MDR) S. Typhi; the remaining 28.6% isolates were without plasmid. Various AMR markers (blaTEM-1, catA, sul1, sul2, dfrA15, strA-strB) and class 1 integron with dfrA7 gene were detected in MDR S. Typhi by PCR and sequencing. Most of the study isolates were likely to be virulent due to the presence of virulence markers. Major diversity was not noticed among S. Typhi and S. Paratyphi A from Kolkata by PFGE. The observed association between AMR profiles and S. Typhi pulsotypes might be useful in controlling the spread of the organism by appropriate intervention. The study reiterated the importance of continuous monitoring of AMR and molecular subtypes of Salmonella isolates from endemic regions for better understanding of the disease epidemiology.

Indexed as

Bacterial ProteinsDrug Resistance, BacterialParatyphoid FeverSalmonella paratyphi ASalmonella typhiTyphoid FeverVirulence FactorsChildChild, PreschoolFemaleHumansIndiaMaleBacterial ProteinsVirulence Factors

Identifiers

PMID25098613
PMCPMC4123848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.